Allergan an ideal candidate to buy Galderma, says Cowen Cowen said earlier today that its talks with industry contacts indicate Nestle (NSRGY) and Loreal may be contemplating a sale of dermatology company Galderma. Cowen believes Allergan (AGN) is an ideal candidate to buy the company given its balance sheet flexibility and keeps an Outperform rating on the stock with a $145 price target. Shares of Allergan are up 3% in morning trading to $99.54.
News For AGN;NSRGY From The Last 14 Days
Check below for free stories on AGN;NSRGY the last two weeks.